Identification and characterization of bacteria isolated from patients with cystic fibrosis in Jordan

References

• Banjar H, Angyalosi G. The road to improving thesurvival of cystic fibrosis patients in arab countries. Int J Pediatr Adolesc Med. 2015;2(2):47–58.
   PubMedGoogle Scholar
• Puchelle E, Bajolet O, Abély M. Airway mucus in cystic fibrosis. Paediatr Respir Rev. 2002;3(2):115–119.
   PubMedGoogle Scholar
• Hauser AR, Jain M, Bar-Meir M, et al. Clinical significance of microbial infection and adaptation in cystic fibrosis. Clin Microbiol Rev. 2011;24(1):29–70.
   PubMed Web of Science ®Google Scholar
• Bascomb S, Manafi M. Use of enzyme tests in characterization and identification of aerobic and facultatively anaerobic gram-positive cocci. Clin Microbiol Rev. 1998;11(2):318–340.
   PubMed Web of Science ®Google Scholar
• Nakasone I, Kinjo T, Yamane N, et al. Laboratory-based evaluation of the colorimetric VITEK-2 compact system for species identification and of the advanced expert system for detection of antimicrobial resistances: VITEK-2 compact system identification and antimicrobial susceptibility testing. Diagn Microbiol Infect Dis. 2007;58(2):191–198.
   PubMed Web of Science ®Google Scholar
• O’hara CM. Manual and automated instrumentation for identification of enterobacteriaceae and other aerobic gram-negative bacilli. Clin Microbiol Rev. 2005;18(1):147–162.
   PubMed Web of Science ®Google Scholar
• Vos P, Garrity G, Jones D, et al. editors. Bergey’s manual of systematic bacteriology: volume 3: the firmicutes. Berlin (Germany): Springer Science & Business Media; 2011.
   Google Scholar
• Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Wayne (PA): CLSI; 2018.
   Google Scholar
• Poirel L, Walsh TR, Cuvillier V, et al. Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis. 2011;70(1):119–123.
   PubMed Web of Science ®Google Scholar
• Corrêa LL, Montezzi LF, Bonelli RR, et al. Revised and updated multiplex PCR targeting acquired 16S rRNA methyltransferases. Int J Antimicrob Agents. 2014;43(5):479–481.
   PubMed Web of Science ®Google Scholar
• Nakhaei Moghaddam M, Forghanifard MM, Moshrefi S. Prevalence and molecular characterization of plasmid-mediated extended-spectrum β-lactamase genes (balaTEM, blaCTX and blASHV) among urinary Escherichia coli clinical isolates in Mashhad, Iran. Iran J Basic Med Sci. 2012;15(3):833–839.
   PubMed Web of Science ®Google Scholar
• Fasihi Y, Saffari F, Kandehkar Ghahraman MR, et al. Molecular detection of macrolide and lincosamide-resistance genes in clinical methicillin-resistant Staphylococcus aureus isolates from Kerman. Iran Arch Pediatr Infect Dis. 2017;5(1):e37761.
   Web of Science ®Google Scholar
• Bolukaoto JY, Monyama CM, Chukwu MO, et al. Antibiotic resistance of Streptococcus agalactiae isolated from pregnant women in garankuwa, South Africa. BMC Res Notes. 2015;8(1):1–7.
   PubMedGoogle Scholar
• Lopardo HA, Vidal P, Jeric P, et al. Six-month multicenter study on invasive infections due to group B streptococci in Argentina. J Clin Microbiol. 2003;41(10):4688–4694.
   PubMed Web of Science ®Google Scholar
• Siddhiqui S, Afreen U, Kotgire S. Evaluation of biofilm formation by three different methods and its antibiogram with special reference to indwelling medical devices from a tertiary care hospital. Ann Pathol Lab Med. 2018;5(2):171–176.
   Google Scholar
• Swedan S, Shubair Z, Almaaytah A. Synergism of cationic antimicrobial peptide WLBU2 with antibacterial agents against biofilms of multi-drug resistant Acinetobacter baumannii and Klebsiella pneumoniae. Infect Drug Resist. 2019;12:2019–2030.
   PubMed Web of Science ®Google Scholar
• Bittar F, Richet H, Dubus JC, et al. Molecular detection of multiple emerging pathogens in sputa from cystic fibrosis patients. PLoS One. 2008;3(8):e2908.
   PubMed Web of Science ®Google Scholar
• Paixão VA, Barros TF, Mota CM, et al. Prevalence and antimicrobial susceptibility of respiratory pathogens in patients with cystic fibrosis. Braz J Infect Dis. 2010;14(4):406–409.
   PubMed Web of Science ®Google Scholar
• Kodori M, Nikmanesh B, Hakimi H, et al. Antibiotic susceptibility and biofilm formation of bacterial isolates derived from pediatric patients with cystic fibrosis from Tehran. Arch Razi Inst. 2021;76(2):397–406.
   PubMedGoogle Scholar
• Mogayzel PJ, Jr Naureckas ET, Robinson KA, et al. Pulmonary clinical practice guidelines committee. Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health. Am J Respir Crit Care Med. 2013;187(7):680–689.
   PubMed Web of Science ®Google Scholar
• Mustafa MH, Chalhoub H, Denis O, et al. Antimicrobial susceptibility of Pseudomonas aeruginosa isolated from cystic fibrosis patients in Northern Europe. Antimicrob Agents Chemother. 2016;60(11):6735–6741.
   PubMed Web of Science ®Google Scholar
• Cikman A, Aydin M, Gulhan B, et al. Absence of the mecC gene in methicillin-resistant Staphylococcus aureus isolated from various clinical samples: the first multi-centered study in Turkey. J Infect Public Health. 2019;12(4):528–533.
   PubMed Web of Science ®Google Scholar
• Vergison A, Denis O, Deplano A, et al. National survey of molecular epidemiology of Staphylococcus aureus colonization in Belgian cystic fibrosis patients. J Antimicrob Chemother. 2007;59(5):893–899.
   PubMed Web of Science ®Google Scholar
• Tkadlec J, Vařeková E, Pantůček R, et al. Characterization of Staphylococcus aureus strains isolated from Czech cystic fibrosis patients: high rate of ribosomal mutation conferring resistance to MLSB antibiotics as a result of long-term and low-dose azithromycin treatment. Microb Drug Resist. 2015;21(4):416–423.
   PubMed Web of Science ®Google Scholar
• Valenza G, Tappe D, Turnwald D, et al. Prevalence and antimicrobial susceptibility of microorganisms isolated from sputa of patients with cystic fibrosis. J Cyst Fibros. 2008;7(2):123–127.
   PubMed Web of Science ®Google Scholar
• Vali P, Shahcheraghi F, Seyfipour M, et al. Phenotypic and genetic characterization of carbapenemase and ESBLs producing gram-negative bacteria (GNB) isolated from patients with cystic fibrosis (CF) in Tehran hospitals. J Clin Diagn. 2014;8(1):26.
   PubMedGoogle Scholar
• Pournajaf A, Razavi S, Irajian G, et al. Integron types, antimicrobial resistance genes, virulence gene profile, alginate production and biofilm formation in Iranian cystic fibrosis Pseudomonas aeruginosa isolates. Infez Med. 2018;26(3):226–236.
   PubMedGoogle Scholar
• Horcajada JP, Montero M, Oliver A, et al. Epidemiology and treatment of multidrug-resistant and extensively drug-resistant Pseudomonas aeruginosa infections. Clin Microbiol Rev. 2019;32(4):e00031.
   PubMed Web of Science ®Google Scholar
• Santana MA, Matos E, Fontoura MD, et al. Prevalence of pathogens in cystic fibrosis patients in Bahia, Brazil. Braz J Infect Dis. 2003;7(1):69–72.
   PubMedGoogle Scholar